TriVascular Technologies, Inc. Announces Preliminary First Quarter Revenue Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Credit Suisse Downgrades TriVascular Technologies (TRIV) to Neutral
April 9, 2015 6:22 AM EDTCredit Suisse downgraded TriVascular Technologies (NASDAQ: TRIV) from Outperform to Neutral with a price target of $10.00 (from $14.00) after the company pre-announced Q1 below the Street and lowered 2015 guidance.
The firm is lowering estimates accordingly.
For an analyst ratings summary and ratings history... More
